Chromium distribution in an oropharyngeal aspiration model for hexavalent chromium in rats

Toxicol Appl Pharmacol. 2022 Dec 15:457:116294. doi: 10.1016/j.taap.2022.116294. Epub 2022 Oct 22.

Abstract

Hexavalent chromium [Cr(VI)] is a well-known and widespread environmental contaminant associated with a variety of adverse health effects, in particular lung cancer. The primary route of exposure in humans is through inhalation. Particulate forms of Cr(VI) are the most potent but in vivo studies are difficult. Intratracheal instillation requires highly trained surgical procedures which also limits the number of repeated exposures possible and thus requires high doses. Inhalation studies can deliver lower more chronic doses but are expensive and generate dangerous aerosols. We evaluated an oropharyngeal aspiration exposure route for zinc chromate particles in Wistar rats. Animals were treated once per week for 90 days. We found chromium accumulated in the lungs, blood, and reproductive tissues of all treated animals. Additionally, we found inflammatory indicators in the lung were elevated and circulating lymphocytes had increased chromosomal damage. These results show oropharyngeal aspiration provides a practicable exposure route for chronic and sub-chronic exposures of Cr(VI) particles.

Keywords: Chromosome Damage; Hexavalent Chromium; Inflammation; Oropharyngeal Aspiration; Particulates.

MeSH terms

  • Animals
  • Chromium* / toxicity
  • Humans
  • Lung
  • Lung Neoplasms* / chemically induced
  • Rats
  • Rats, Wistar

Substances

  • chromium hexavalent ion
  • Chromium